Currently out of the existing stock ratings of Yun Zhong, 46 are a BUY (82.14%), 10 are a HOLD (17.86%).

Yun Zhong

Work Performance Price Targets & Ratings Chart

Analyst Yun Zhong works with a stock forecast success ratio of 19.12% fulfilled within 85.35 days on average. Previously, Yun Zhong worked at BTIG.

Yun Zhong’s has documented 97 price targets and ratings displayed on 17 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on PASG, Passage Bio at 06-Mar-2023.

Wall Street Analyst Yun Zhong

Analyst best performing recommendations are on GRPH (GRAPHITE BIO).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.

Average potential price target upside

AGTC Applied Genetic AVRO AVROBIO MGTA Magenta Therapeutics QURE Uniqure NV SIOX Sio Gene Therapies SRPT Sarepta Therapeutics TSHA Taysha Gene Therapies  PASG Passage Bio AVXL Anavex Life Sciences Corp FOLD Amicus Therapeutics FRLN Freeline Therapeutics Holdings Plc GRPH Graphite Bio BLUE Bluebird bio FUTU Futu Holdings Ltd INSY INSYS Therapeutics RCOR Renovacor SELB Selecta Biosciences

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$0.01 (2.56%)

1 years 5 months 19 days ago

1/1 (100%)

$0.01 (2.56%)



1 years 5 months 20 days ago

1/10 (10%)

$13.99 (348.88%)




1 years 5 months 20 days ago

0/2 (0%)

$2.73 (29.45%)


1 years 5 months 20 days ago

0/1 (0%)

$7.55 (308.16%)



1 years 6 months 15 days ago

0/2 (0%)

$6.72 (157.01%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Yun Zhong?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?